- Condition: Asthma
Interventions: Drug: MEMP1972A; Drug: MEMP1972A; Drug: MEMP1972A; Drug: placebo
Sponsors: Genentech; Genentech
Not yet recruiting - verified April 2012 - Condition: Asthma
Interventions: Drug: Albuterol 25 mcg, Placebo; Drug: Albuterol 0.25 mcg; Drug: Albuterol 90 mcg, Placebo; Drug: Albuterol, 90 mcg; Drug: Placebo; Drug: Proventil 90 mcg; Drug: Proventil 90 mcg
Sponsors: Amphastar Pharmaceuticals, Inc.; Amphastar Pharmaceuticals, Inc.
Recruiting - verified April 2012 - Condition: Asthma
Interventions: Drug: Fluticasone propionate DPI Dose 1; Drug: Fluticasone propionate DPI Dose 2; Drug: Fluticasone propionate DPI Dose 3; Drug: Fluticasone propionate DPI Dose 4; Other: Placebo DPI; Drug: Flovent Diskus 250 mcg
Sponsors: Teva Pharmaceutical Industries; Teva Pharmaceutical Industries
Not yet recruiting - verified May 2012 - Condition: Food Hypersensitivity
Interventions: Other: Amino Acid formula; Other: Commercially available Amino Acid Formula
Sponsors: Nestlé Nutrition Corporate; Nestlé Nutrition Corporate
Not yet recruiting - verified April 2012 - Condition: Mild to Moderate Atopic Dermatitis
Intervention: Drug: HL-009 Liposomal Gel
Sponsors: HanAll BioPharma Co., Ltd.; HanAll BioPharma Co., Ltd.
Recruiting - verified March 2012 - Condition: Asthma
Interventions: Drug: ARRY-502, CRTh2 antagonist; oral; Drug: Placebo; oral
Sponsors: Array BioPharma; Array BioPharma
Recruiting - verified May 2012 - Condition: Asthma
Interventions: Drug: Fluticasone Furoate; Drug: Fluticasone Propionate; Drug: Placebo
Sponsors: GlaxoSmithKline; GlaxoSmithKline
Not yet recruiting - verified March 2012 - Condition: Asthma
Interventions: Drug: Fluticasone propionate 100mcg; Drug: Placebo; Drug: Vilanterol
Sponsors: GlaxoSmithKline; GlaxoSmithKline
Not yet recruiting - verified April 2012 - Condition: Asthma
Interventions: Drug: lebrikizumab; Drug: lebrikizumab; Drug: lebrikizumab; Drug: placebo
Sponsors: Genentech; Genentech
Recruiting - verified April 2012 - Condition: Asthma
Interventions: Drug: lebrikizumab; Drug: lebrikizumab; Drug: lebrikizumab; Drug: placebo
Sponsors: Genentech; Genentech
Recruiting - verified April 2012 - Condition: Asthma
Interventions: Drug: ONO-6950; Drug: ONO-6950; Drug: Montelukast; Drug: Placebo
Sponsors: Ono Pharma; Ono Pharma; Ono Pharmaceutical Co. Ltd
Recruiting - verified March 2012 - Condition: Asthma
Intervention: Drug: Nebulized magnesium sulfate
Sponsors: University of Texas Southwestern Medical Center; University of Texas Southwestern Medical Center
Recruiting - verified September 2011 - Condition: Eosinophilic Asthma
Interventions: Drug: Reslizumab; Drug: Matching Placebo
Sponsors: Teva Pharmaceutical Industries; Cephalon
Recruiting - verified May 2012 - Condition: Asthma
Interventions: Drug: Mometasone Furoate (MF) Metered Dose Inhaler (MDI), 25 mcg; Drug: Mometasone Furoate (MF) Metered Dose Inhaler (MDI), 50 mcg; Drug: Mometasone Furoate (MF) Metered Dose Inhaler (MDI), 100 mcg; Drug: Mometasone Furoate (MF) Dry Powder Inhaler (DPI), 100 mcg; Drug: Placebo Metered Dose Inhaler (MDI); Drug: Placebo Dry Powder Inhaler (DPI)
Sponsors: Schering-Plough; Schering-Plough
Recruiting - verified April 2012 - Condition: Asthma
Interventions: Drug: Placebo; Drug: Flovent Diskus; Drug: Fluticasone propionate DPI Dose 1; Drug: Fluticasone propionate DPI Dose 2; Drug: Fluticasone propionate DPI Dose 3; Drug: Fluticasone propionate DPI Dose 4
Sponsors: Teva Pharmaceutical Industries; Teva Pharmaceutical Industries; PPD
Recruiting - verified May 2012 - Condition: Asthma
Interventions: Drug: Placebo; Drug: Primatene Mist; Drug: Epinephrine inhalation aerosol, HFA; Drug: epinephrine inhalation aerosol
Sponsors: Amphastar Pharmaceuticals, Inc.; Amphastar Pharmaceuticals, Inc.
Recruiting - verified November 2011 - Condition: Asthma
Interventions: Drug: Mometasone Furoate/Formoterol MDI 100/5 mcg; Drug: Mometasone Furoate/Formoterol MDI 200/5 mcg; Drug: Mometasone Furoate MDI 100 mcg; Drug: Mometasone Furoate MDI 200 mcg; Drug: Albuterol 90 mcg /salbutamol 100 mcg HFA MDI; Drug: Prednisone/prednisolone
Sponsors: Schering-Plough; Schering-Plough
Recruiting - verified April 2012 - Condition: Asthma
Intervention: Drug: Epinephrine Inhalation Aerosol
Sponsors: Amphastar Pharmaceuticals, Inc.; Amphastar Pharmaceuticals, Inc.
Recruiting - verified October 2011 - Condition: Seasonal Allergic Rhinitis
Interventions: Drug: Ciclesonide nasal aerosol 37 mcg; Drug: ciclesonide nasal aerosol 74 mcg; Drug: Placebo
Sponsors: Sunovion; Sunovion
Recruiting - verified April 2012 - Condition: Peanut Allergy
Interventions: Drug: QGE031; Drug: Placebo
Sponsors: Novartis; Novartis Pharmaceuticals
Not yet recruiting - verified March 2012 - Condition: Hereditary Angioedema
Intervention: Drug: Icatibant
Sponsors: Massachusetts General Hospital; Massachusetts General Hospital; Shire Human Genetic Therapies, Inc.
Recruiting - verified April 2012 - Conditions: Perennial Allergic Rhinitis; PAR
Interventions: Drug: Ciclesonide nasal aerosol 37 mcg; Drug: ciclesonide nasal aerosol 74 mcg; Drug: Placebo
Sponsors: Sunovion; Sunovion
Recruiting - verified March 2012 - Condition: Asthma
Interventions: Drug: Symbicort pMDI; Drug: Symbicort pMDI; Drug: budesonide pMDI; Drug: budesonide pMDI
Sponsors: AstraZeneca; AstraZeneca
Recruiting - verified March 2012 - Condition: Asthma
Interventions: Drug: Fluticasone furoate 50mcg; Drug: Fluticasone propionate 100mcg; Drug: Placebo
Sponsors: GlaxoSmithKline; GlaxoSmithKline
Recruiting - verified March 2012 - Condition: Asthma
Interventions: Drug: Fluticasone furoate 50mcg; Drug: Placebo
Sponsors: GlaxoSmithKline; GlaxoSmithKline
Recruiting - verified April 2012 - Condition: Asthma
Interventions: Drug: QAW039; Drug: Comparator leukotriene receptor antagonist (LRTA); Drug: Placebo
Sponsors: Novartis; Novartis Pharmaceuticals
Recruiting - verified May 2012 - Condition: Asthma
Interventions: Biological: Omalizumab; Drug: Fluticasone; Other: Placebo
Sponsors: National Institute of Allergy and Infectious Diseases (NIAID); National Institute of Allergy and Infectious Diseases (NIAID)
Recruiting - verified February 2012 - Conditions: Healthy Volunteers; Atopic Dermatitis; Netherton Syndrome
Interventions: Drug: BPR277 ointment (controlled application); Drug: Placebo (Vehicle); Drug: BPR277 ointment; Drug: Placebo (Vehicle); Drug: BPR277; Drug: Placebo (Vehicle)
Sponsors: Novartis; Novartis
Recruiting - verified November 2011 - Condition: Asthma
Intervention: Drug: Tralokinumab
Sponsors: MedImmune LLC; MedImmune LLC
Recruiting - verified January 2012 - Condition: Hereditary Angioedema
Intervention: Drug: icatibant
Sponsors: Shire Human Genetic Therapies, Inc.; Shire Human Genetic Therapies, Inc.
Recruiting - verified May 2012 - Condition: Asthma
Intervention: Drug: Flovent Diskus, Advair Diskus, Ventolin HFA, cetirizine, Flonase Nasal Spray, Singulair
Sponsors: National Institute of Allergy and Infectious Diseases (NIAID); National Institute of Allergy and Infectious Diseases (NIAID)
Recruiting - verified August 2011 - Condition: ACE Inhibitor Induced Angioedema
Interventions: Drug: ecallantide; Drug: ecallantide; Drug: ecallantide; Drug: placebo
Sponsors: Dyax Corp.; Dyax Corp.
Recruiting - verified April 2012 - Condition: Severe Asthma
Intervention: Device: Alair System
Sponsors: Asthmatx, Inc.; Asthmatx, Inc.; Boston Scientific Corporation
Recruiting - verified March 2012 - Condition: Asthma
Interventions: Biological: SAR231893 (REGN668); Drug: placebo
Sponsors: Sanofi-Aventis; Sanofi-Aventis; Regeneron Pharmaceuticals
Recruiting - verified April 2012 - Condition: Eosinophilic Asthma
Interventions: Drug: Reslizumab; Drug: Placebo
Sponsors: Cephalon; Cephalon
Recruiting - verified April 2012 - Condition: Eosinophilic Asthma
Interventions: Drug: Reslizumab; Drug: Placebo
Sponsors: Cephalon; Cephalon
Recruiting - verified April 2012 - Condition: Food Hypersensitivity
Interventions: Other: Extensively hydrolyzed, whey protein infant formula; Other: Extensively hydrolyzed, casein protein infant formula
Sponsors: Nestlé Nutrition Corporate; Nestlé Nutrition Corporate
Recruiting - verified March 2012 - Condition: Egg Allergy
Intervention: Biological: Trivalent Influenza Vaccine
Sponsors: University of Michigan Health System; University of Michigan Health System; American College of Allergy, Asthma and Immunology
Recruiting - verified October 2011 - Condition: Eosinophilic Asthma
Interventions: Drug: Reslizumab; Drug: Reslizumab; Drug: Placebo
Sponsors: Teva Pharmaceutical Industries; Cephalon
Recruiting - verified April 2012 - Condition: Dermatitis
Interventions: Biological: REGN668; Biological: REGN668; Biological: REGN668
Sponsors: Regeneron Pharmaceuticals; Regeneron Pharmaceuticals; Sanofi-Aventis
Recruiting - verified February 2012 - Condition: Asthma
Interventions: Drug: tiotropium Respimat low dose; Drug: tiotropium Respimat high dose; Drug: placebo Respimat
Sponsors: Boehringer Ingelheim Pharmaceuticals; Boehringer Ingelheim Pharmaceuticals; Pfizer
Recruiting - verified May 2012 - Conditions: Asthma; Health
Intervention: Other: All patients
Sponsors: Centocor, Inc.; Centocor, Inc.
Recruiting - verified April 2012 - Conditions: Depression; Asthma
Interventions: Drug: Escitalopram; Drug: Placebo
Sponsors: University of Texas Southwestern Medical Center; University of Texas Southwestern Medical Center; National Heart, Lung, and Blood Institute (NHLBI)
Recruiting - verified March 2012 - Condition: Hereditary Angioedema
Interventions: Drug: rhC1INH; Drug: Placebo (Saline)
Sponsors: Pharming Technologies B.V.; Pharming Technologies B.V.
Recruiting - verified April 2012 - Condition: Asthma
Interventions: Drug: budesonide; Drug: placebo
Sponsors: AstraZeneca; AstraZeneca
Recruiting - verified May 2012 - Conditions: Asthma; Rhinitis; Sinusitis
Interventions: Drug: Mometasone Furoate monohydrate; Other: Placebo
Sponsors: American Lung Association Asthma Clinical Research Centers; American Lung Association Asthma Clinical Research Centers; National Institutes of Health (NIH); National Heart, Lung, and Blood Institute (NHLBI)
Recruiting - verified June 2011 - Condition: Includes: Hereditary Angioedema
Intervention: Biological: Berinert® (C1 Esterase Inhibitor)
Sponsors: CSL Behring; CSL Behring; Chiltern International Inc.
Recruiting - verified May 2012 - Condition: Tumor Lysis Syndrome
Intervention:
Sponsors: Sanofi-Aventis; Sanofi-Aventis
Recruiting - verified February 2012 - Condition: Hereditary Angioedema
Intervention: Biological: Cinryze
Sponsors: ViroPharma; ViroPharma
Recruiting - verified April 2011 - Condition: Asthma
Interventions: Drug: Imatinib mesylate; Drug: Placebo
Sponsors: Brigham and Women's Hospital; Brigham and Women's Hospital; Harvard Clinical Research Institute; National Heart, Lung, and Blood Institute (NHLBI)
Recruiting - verified March 2012 - Condition: Hereditary Angioedema
Intervention: Drug: ecallantide
Sponsors: Dyax Corp.; Dyax Corp.
Recruiting - verified April 2012 - Condition: ASTHMA
Interventions: Behavioral: Capnometry Assisted Respiration Training; Behavioral: Breathing Awareness
Sponsors: Southern Methodist University; Southern Methodist University; National Heart, Lung, and Blood Institute (NHLBI); Baylor Health Care System
Recruiting - verified September 2009 - Conditions: Hypertension; Asthma
Interventions: Other: PPCM Asthma; Other: 24 Month PPCM BP; Other: 9 Month PPCM HTN
Sponsors: University of Iowa; University of Iowa
Recruiting - verified June 2010 - Conditions: Psoriasis; Atopic Dermatitis
Interventions: Other: Blood pressure; Other: Height; Other: Weight; Other: BMI; Other: Waist Circumference
Sponsors: Northwestern University; Northwestern University
Recruiting - verified September 2011 - Condition: Asthma
Interventions: Drug: Levalbuterol; Drug: Levalbuterol UDV TID; Drug: Placebo
Sponsors: Sunovion; Sunovion
Recruiting - verified February 2012 - Condition: Atopic Dermatitis
Intervention:
Sponsors: Astellas Pharma Inc; Astellas Pharma Inc
Recruiting - verified March 2012
 |
Join Clinical Trials in Texas for Allergies |
